Keudell Eli Lilly & CO Transaction History

Keudell

$366 Million
Q3 2024

A detailed history of Keudell transactions in Eli Lilly & CO stock. As of the latest transaction made, Keudell holds 5,006 shares of LLY stock, worth $3.75 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

5,006

Previous 4,820 3.86%

Holding current value

$3.75 Million

Previous $4.36 Million 1.65%

% of portfolio

1.21%

Previous 1.28%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$772.14 - $960.02 $143,618 - $178,563	186 Added 3.86%	5,006 $4.44 Million
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $102,206 - $128,174	-141 Reduced 2.84%	4,820 $4.36 Million
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $206,677 - $276,505	349 Added 7.57%	4,961 $3.86 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $455,864 - $537,404	868 Added 23.18%	4,612 $2.69 Million
Q3 2023 Oct 18, 2023	BUY	$434.7 - $599.3 $35,210 - $48,543	81 Added 2.21%	3,744 $2.01 Million
Q2 2023 Jul 20, 2023	BUY	$350.74 - $468.98 $31,566 - $42,208	90 Added 2.52%	3,663 $1.72 Million
Q1 2023 Apr 18, 2023	BUY	$310.63 - $364.82 $34,479 - $40,495	111 Added 3.21%	3,573 $1.23 Million
Q4 2022 Jan 20, 2023	SELL	$321.55 - $374.67 $62,380 - $72,685	-194 Reduced 5.31%	3,462 $0
Q3 2022 Oct 12, 2022	SELL	$296.48 - $337.87 $103,768 - $118,254	-350 Reduced 8.74%	3,656 $1.18 Million
Q2 2022 Jul 18, 2022	BUY	$278.73 - $327.27 $5,574 - $6,545	20 Added 0.5%	4,006 $1.3 Million
Q1 2022 Apr 18, 2022	SELL	$234.69 - $291.66 $35,203 - $43,749	-150 Reduced 3.63%	3,986 $1.14 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $17,088 - $21,207	-76 Reduced 1.8%	4,136 $1.14 Million
Q3 2021 Oct 20, 2021	BUY	$221.6 - $272.71 $4,653 - $5,726	21 Added 0.5%	4,212 $973,000
Q3 2020 Oct 20, 2020	SELL	$146.22 - $169.13 $7,311 - $8,456	-50 Reduced 1.18%	4,191 $620,000
Q2 2020 Jul 14, 2020	SELL	$136.42 - $164.18 $818 - $985	-6 Reduced 0.14%	4,241 $696,000
Q1 2020 Apr 20, 2020	BUY	$119.05 - $147.35 $62,144 - $76,916	522 Added 14.01%	4,247 $589,000
Q2 2019 Aug 23, 2019	BUY	$110.79 - $129.32 $412,692 - $481,717	3,725 New	3,725 $414,000
Q2 2019 Aug 21, 2019	SELL	$110.79 - $129.32 $468,087 - $546,377	-4,225 Closed	0 $0
Q1 2019 Aug 21, 2019	BUY	$111.31 - $131.02 $470,284 - $553,559	4,225 New	4,225 $548,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.

Account